Amedisys Inc
SWB:ADY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Amedisys Inc (ADY) under the Base Case is 52.86 EUR per share. Compared with the current market price of 85 EUR, the stock appears Overvalued by 38% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Amedisys Does
Amedisys Inc., headquartered in Baton Rouge, Louisiana, has crafted its narrative at the forefront of America's healthcare sector, by focusing squarely on providing quality home health and hospice services. Established in 1982, the company has steadily expanded its reach, now operating in more than 30 states with a strong network of healthcare professionals dedicated to delivering comprehensive care at the patient's doorstep.
- Headquarters
- United States of America US
- Employees
- 21 000
- IPO date
- Aug 17, 1994
Amedisys has no economic moat
Amedisys Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Amedisys Inc
Earnings Waterfall
Amedisys Inc
Continue ADY Research
Decided on Amedisys? Get an email when ADY reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one ADY stock?
The intrinsic value for Amedisys Inc (ADY) under the Base Case is 52.86 EUR.
Is ADY stock undervalued or overvalued?
Compared with the current market price of 85 EUR, the stock appears Overvalued by 38% .